title: Cervical cancer in pregnant women: treat, wait or interrupt? Assessment of current clinical guidelines, innovations and controversies.
abstract: Cervical cancer during pregnancy is relatively uncommon. However, the incidence is expected to increase as more women delay childbearing. When preservation of the pregnancy is desired, optimal treatment is a major challenge to all. Whereas delay of treatment is an option for pre-invasive disease, and also small invasive carcinomas without lymph node involvement, management of tumours >2 cm remains experimental. Type of treatment needs to be individualized and depends mainly on gestational age, disease stage, and histology. Extensive counselling regarding the maternal and foetal risks is required. In this current review, we aim to summarize available data and treatment guidelines concerning cervical cancer in pregnancy. Controversies and research priorities are also identified.
authors.affiliation: Leuven Cancer Institute (LKI), Gynaecologic Oncology, University Hospitals Leuven, and Department of Oncology, KU Leuven, Belgium.
authors.forename: Sileny N
authors.initials: SN
authors.lastname: Han
authors.forename: Mina
authors.initials: M
authors.lastname: Mhallem Gziri
authors.forename: Kristel
authors.initials: K
authors.lastname: Van Calsteren
authors.forename: Frédéric
authors.initials: F
authors.lastname: Amant
keywords: cervical cancer; chemotherapy; neonatal; pregnancy